Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of changes to the allocation of NHS training places included in the Medical Training (Prioritisation) Bill on UK medical students studying at foreign campuses of UK universities.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Medical Training (Prioritisation) Bill was introduced to Parliament on 13 January 2026. The bill delivers the Government’s commitment in the 10-Year Health Plan for England, published in July 2025, to prioritise United Kingdom medical graduates for foundation training, and to prioritise UK medical graduates and other doctors who have worked in the National Health Service for a significant period for specialty training.
Under the bill, British citizens who have graduated from medical schools outside of the UK will not be prioritised for foundation training places, and a graduate from a medical school in the UK or Ireland will not be prioritised if they spent the majority of their time studying outside the British Islands.
For specialty training places starting in 2026, NHS experience is being represented by immigration status as people with a settled immigration status are more likely to have worked in the NHS for longer. The effect of this is that British citizens and those with certain other immigration status will be prioritised. For specialty training posts starting from 2027 onwards, this provision will not apply automatically. Instead, it will be possible to make regulations to specify additional groups who will be prioritised, where they are likely to have significant experience working as a doctor either in the NHS in England, Scotland, or Wales or in health and social care in Northern Ireland, or by reference to their immigration status.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of introducing mandatory training for GPs on (a) identifying symptoms and (b) offering treatment for the Menopause.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We know that more needs to be done to support women experiencing the menopause. This Government is committed to prioritising women’s health as we reform the NHS.
General practitioners are responsible for ensuring their own clinical knowledge, including on menopause, remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by the National Institute for Health and Care Excellence (NICE), to ensure that they can continue to provide high quality care to all patients.
All United Kingdom registered doctors are expected to meet the professional standards set out in the General Medical Council’s (GMC’s) Good Medical Practice. The training curriculum for postgraduate trainee doctors is set by the Royal College of General Practitioners and has to meet the standards set by the GMC.
NICE published its updated guideline in November 2024 and recommended more treatment choices for menopause symptoms. The updated guideline aims to support healthcare professionals by providing them with information they need to support evidence-based decisions about treatment choices, as well as information and support about menopause. The guideline recommends hormone replacement therapy (HRT) as the most effective treatment for vasomotor symptoms, and also recommends that for people aged over 40 years old, healthcare professionals should consider menopause-specific cognitive behavioural therapy as an option for vasomotor symptoms associated with menopause in addition to HRT. HRT is the main treatment for menopause symptoms, and NICE recommends that for most women it is safe and effective.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the diagnosis of the menopause for BAME women.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government acknowledges the challenges women face in seeking a diagnosis and support for menopause symptoms and that these are especially acute amongst certain groups, including those from an ethnic minority background.
We are clear that more needs to be done to address these barriers and that is why we announced earlier this year that menopause will be included in routine NHS Health Checks for over 40 year olds, raising awareness of symptoms and giving women the confidence to seek help. To improve uptake of the NHS Health Check we have developed a new NHS Health Check online service, currently being piloted in multiple local authorities, which people can use at home, at a time that is convenient for them.
As part of the Government’s renewal of the Women’s Health Strategy, we will look to identify specific barriers in access to healthcare and set out concrete action to remove them.
Through our National Institute for Health and Care Research, we have invested over £4 million into research on menopause in 2024/25. This includes research to understand Black women's experiences of digitally provided sexual and reproductive healthcare including on the menopause.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment has he made of the adequacy of the (a) diagnosis and (b) treatment of the menopause for BAME women in (i) Hounslow, (ii) West London and (iii) London.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government acknowledges the challenges women face in seeking a diagnosis and support for menopause symptoms and that these are especially acute amongst certain groups, including those from an ethnic minority background.
We are clear that more needs to be done to address these barriers, and that is why we announced earlier this year that menopause will be included in routine NHS Health Checks for those who are 40 years old and over, raising awareness of symptoms and giving women the confidence to seek help. To improve uptake of the NHS Health Check we have developed a new NHS Health Check online service, currently being piloted in multiple local authorities, which people can use at home, at a time convenient to them.
In North West London, our approach to menopause care is guided by the Women’s Health Strategy, which sets out a 10-year vision to improve access, tackle taboos, and ensure that ethnicity does not impact the quality of care. While menopause support is primarily delivered through primary care and specialist referral pathways, the strategy commits to reducing health inequalities by providing culturally appropriate information and improving awareness among underserved communities. We continue to work with local partners to address barriers such as stigma and language, and to ensure that women from all backgrounds, including Black, Asian, and minority ethnic communities, can access timely diagnosis and treatment.
The Government is committed to prioritising women’s health as we reform the National Health Service, and women’s equality will be at the heart of our missions, our 10-Year Health Plan, and the renewal of the Women’s Health Strategy.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that communications from NHS trusts to deaf and deafblind patients are accessible.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Integrated care boards are responsible for commissioning services to meet the health needs of their local population, which includes responsibility for ensuring that there is adequate provision of British Sign Language interpreters to support deaf patients in the community.
Nationally, all National Health Service organisations and publicly funded social care providers are expected to meet the Accessible Information Standard (AIS), which details the approach to supporting the information and communication support needs of people with a disability, impairment, or sensory loss. This includes support for deaf and deafblind patients.
NHS England published a revised AIS on 30 June 2025. NHS England is working to support implementation of the AIS with awareness raising, communication, and engagement, and a review of the current e-learning modules on the AIS. The intention is to ensure that staff and organisations in the NHS are aware of the AIS and the importance of meeting the information and communication needs of disabled people using services.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department plans to review the NICE guidelines on NHS-funded IVF treatment to allow for exceptions in cases where (a) short-term illness and (b) clinical advice from NHS staff has prevented a person from starting IVF treatment before the age eligibility cut-off.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for ensuring that its guidelines are up to date in light of changes to the evidence and clinical practice. NICE’s guideline on the management of fertility problems is currently being updated, with draft guidance due to be issued for consultation shortly. NICE guidelines are not intended to cover every health condition, clinical scenario, or treatment. In the absence of NICE guidance, there is an expectation that clinicians and the relevant commissioners make decisions on the most appropriate treatment for the people in their care.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with NHS England on screening new born children for Spinal Muscular Atrophy.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK National Screening Committee (UK NSC) has been working with partners to scope an in-service evaluation of newborn screening for spinal muscular atrophy (SMA) in real world National Health Services in the United Kingdom.
The research brief that will inform this in-service evaluation has now been published, and the call for applicants is live.
Results from the in-service evaluation, along with a new SMA screening modelling study, will inform any recommendation made by the UK NSC on whether to screen newborn babies for this condition.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve screening of new born children for Spinal Muscular Atrophy.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK National Screening Committee (UK NSC) has been working with partners to scope an in-service evaluation of newborn screening for spinal muscular atrophy (SMA) in real world National Health Services in the United Kingdom.
The research brief that will inform this in-service evaluation has now been published, and the call for applicants is live.
Results from the in-service evaluation, along with a new SMA screening modelling study, will inform any recommendation made by the UK NSC on whether to screen newborn babies for this condition.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of mammograms available for women over the aged of 50 in West London.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England is committed to providing equitable access to breast screening services for eligible women aged 50 years old and over across the country, including in West London.
In West London, women aged 50 to 70 years old are invited for breast screening every three years as part of the NHS Breast Screening Programme, to the screening sites at the West of London Breast Screening Service (WOLBSS). There has been a surge in demand recently, following the disruption caused during the COVID-19 pandemic.
To address the increased demand for screening services post-COVID recovery, NHS England is working with the WOLBSS to improve appointment availability. This includes extending clinic hours, offering weekend clinics, investing in workforce recruitment and training, and targeting areas with lower screening uptake.
The information requested on average waiting times is not held centrally for screening mammograms.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average waiting time is for women aged over 50 to receive a mammogram.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England is committed to providing equitable access to breast screening services for eligible women aged 50 years old and over across the country, including in West London.
In West London, women aged 50 to 70 years old are invited for breast screening every three years as part of the NHS Breast Screening Programme, to the screening sites at the West of London Breast Screening Service (WOLBSS). There has been a surge in demand recently, following the disruption caused during the COVID-19 pandemic.
To address the increased demand for screening services post-COVID recovery, NHS England is working with the WOLBSS to improve appointment availability. This includes extending clinic hours, offering weekend clinics, investing in workforce recruitment and training, and targeting areas with lower screening uptake.
The information requested on average waiting times is not held centrally for screening mammograms.